This report presents a strategic analysis of the US Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the US Vitamin and Minerals Market, offering unmatched value, accuracy, and expert insights.
The United States is the world's largest economy, ahead of China. Following the COVID-19 epidemic, the country's GDP growth rate turned negative, exacerbated by rising disparities and outmoded infrastructure, which are slowing down potential GDP growth. However, the country's output recession in 2020 was less severe than that of other large advanced countries, and the country quickly recovered from the shock, with GDP already recovering to pre-pandemic levels in Q2/2021.
Healthcare in the US is more expensive than in most other countries. According to the Commonwealth Fund, the US spent approximately 17.7% of its GDP on healthcare in 2019. The second-highest-ranking country, Switzerland, spent 12.2 percent of its GDP. Surprisingly, New Zealand and Australia only devote 9.3%, or half as much as the US.
COVID-19's emergence has impacted millions of people around the world, as well as various industrial sectors. The outbreak of the Coronavirus has had a significant impact on OTC medicine sales, with a greater focus on personal health during the pandemic. This has resulted in a considerable increase in the consumption of cold and flu medications, as well as vitamins. However, OTC medicine sales were prohibited in some areas to prevent stockpiling and sustain supplies. As a result, the pandemic has had a favorable influence on business, as well as a moderately negative impact in some locations, and the industry is expected to witness an increase in demand as COVID-19 prevalence declines in various nations.
Over the next few years, the emerging countries of Latin America and Southeast Asia are expected to have the fastest increase in the worldwide over-the-counter (OTC) pharmaceuticals industry. This is due to the fast-rising population in these areas, as well as the growing middle class and growth in disposable income, which will create a critical mass of people who will be able to acquire OTC medications. Supermarkets are also contributing to the rise of the OTC pharmaceutical market in emerging economies, along with new channels of accessibility at retail outlets in emerging markets.
The rising demand for dietary supplements, which are utilized as an alternative to prescription medications to treat a variety of health concerns like obesity, diabetes, and heart disease, is what is driving the expansion of this market. Consumption of vitamins and minerals has increased recently as a result of consumers' rising understanding of the advantages of these goods.
The U.S. Vitamin and Minerals Market size is at around US $ 21.4 Bn in 2021 and is projected to reach US $ 30.5 Bn in 2030.
Market Growth Drivers Analysis
Consumers' increased interest in health and wellbeing, their changing lifestyles, and their readiness to adopt healthier dietary choices are all indicators of the rising demand for vitamins and minerals in the US market. The COVID-19 pandemic also had a favourable impact on consumers' perspectives toward leading healthy lives, which in turn increased demand for vitamins and minerals. The market for vitamins and minerals will grow as consumer preferences for better lifestyles and rising purchasing power as a result of economic developments increase.
Key Players
The prominent players operating in this market include Amway, INFINITUS, Herbalife Nutrition, DEEJ, Usana, Blackmores, PERFECT (CHINA), Swisse, China New Era Group, By-health, Suntory, Pfizer, Beijing Tong Ren Tang, Shanghai Pharma, TIENS, GNC, Real Nutriceutical, Southernature
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
The vitamin & minerals market is segmented as mentioned below:
By Type (Revenue, USD Billion):
By Application (Revenue, USD Billion):
By Sales Channel (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.